These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27824082)

  • 1. MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1α and p53 pathways.
    Tang W; Dong K; Li K; Dong R; Zheng S
    Sci Rep; 2016 Nov; 6():36268. PubMed ID: 27824082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc01105 acts as an oncogene in the development of neuroblastoma.
    Ye M; Ma J; Liu B; Liu X; Ma D; Dong K
    Oncol Rep; 2019 Oct; 42(4):1527-1538. PubMed ID: 31524279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.
    Zhou C; Huang C; Wang J; Huang H; Li J; Xie Q; Liu Y; Zhu J; Li Y; Zhang D; Zhu Q; Huang C
    Oncogene; 2017 Jul; 36(27):3878-3889. PubMed ID: 28263966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
    Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
    Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
    [No Abstract]   [Full Text] [Related]  

  • 5. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
    Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
    Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
    Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
    Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1α contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling.
    Chen S; Zhang M; Xing L; Wang Y; Xiao Y; Wu Y
    PLoS One; 2015; 10(3):e0121115. PubMed ID: 25811359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA MEG3 mediated angiogenesis after cerebral infarction through regulating p53/NOX4 axis.
    Zhan R; Xu K; Pan J; Xu Q; Xu S; Shen J
    Biochem Biophys Res Commun; 2017 Aug; 490(3):700-706. PubMed ID: 28634073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway.
    Wei GH; Wang X
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3850-3856. PubMed ID: 28975980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalin inhibits proliferation and promotes apoptosis of vascular smooth muscle cells by regulating the MEG3/p53 pathway following treatment with ox‑LDL.
    Liu Y; Jia L; Min D; Xu Y; Zhu J; Sun Z
    Int J Mol Med; 2019 Feb; 43(2):901-913. PubMed ID: 30535498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition.
    Ye M; Lu H; Tang W; Jing T; Chen S; Wei M; Zhang J; Wang J; Ma J; Ma D; Dong K
    Int J Biol Sci; 2020; 16(15):3050-3061. PubMed ID: 33061817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression.
    Ye M; Gao R; Chen S; Wei M; Wang J; Zhang B; Wu S; Xu Y; Wu P; Chen X; Ma J; Ma D; Dong K
    J Cell Mol Med; 2022 Apr; 26(8):2377-2391. PubMed ID: 35257481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
    Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
    J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
    He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
    J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke.
    Yan H; Yuan J; Gao L; Rao J; Hu J
    Neuroscience; 2016 Nov; 337():191-199. PubMed ID: 27651151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
    Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
    Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.